Director's Dealings
ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
(“Ascendis” or “the Company”)
Dealings in securities by directors
In terms of paragraphs 3.63 to 3.65 of the JSE Limited (“the JSE”) Listings Requirements ("the Listings
Requirements"), the following information, relating to dealings in securities by directors, is disclosed:
Directors: Gary John Shayne and Crispian Dillon
Nature of the transaction: Following on from the Ascendis SENS announcement
released on 7 November 2014 pertaining to the capital
raise of the Company, Coast2Coast Investments
Proprietary Limited (“C2C”) participated in the
secondary placement by way of a minor sell down of
its shareholding in the Company, which equates to a
decrease of its shareholding in Ascendis by c.4%,
which was motivated to facilitate ancillary
opportunities.
Gary Shayne holds an 85% indirect interest in C2C
and Crispian Dillon holds a 15% indirect interest in
C2C.
Number of shares: 5,734,000
Selling price per share: R15.00
Value: R86,010,000
Date of transaction: 7 November 2014
Class of shares: Ordinary shares
Nature of transaction: Sale, off market
Nature of interest: Direct Beneficial
Written clearance obtained: Clearance was obtained from the Chairman of the
Board
7 November 2014
Johannesburg
Sponsor
Investec Bank Limited
Date: 07/11/2014 03:10:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.